Evidence map›Paper›PMID 31895219›Full record

ArticleInvestigative radiology2020

Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation.

Iliyana Atanasova, Mozhdeh Sojoodi, Helena S Leitão, Sergei Shuvaev, Carlos F G C Geraldes, Ricard Masia, Alexander S Guimaraes, Kenneth K Tanabe, Bryan C Fuchs, Peter Caravan

Open access · greenAbstract read
In one paragraph

Article in Investigative radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Fibrin-targeting molecular MRI in inflammatory CNS disorders.European journal of nuclear medicine and molecular imaging · 2022
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Iliyana AtanasovaFrom the Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital.
Mozhdeh SojoodiDivision of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Helena S LeitãoDepartment of Biomedical Sciences and Medicine and University Hospital Center, University of Algarve, Faro.
Sergei ShuvaevFrom the Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital.
Carlos F G C GeraldesDepartment of Life Sciences and Coimbra Chemistry Center, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal.
Ricard MasiaDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Alexander S GuimaraesFrom the Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital.
Kenneth K TanabeDivision of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Bryan C FuchsDivision of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Peter Caravan
Massachusetts General Hospital · USAthinoula A. Martinos Center for Biomedical Imaging · USHarvard University · USUniversity of Algarve · PTUniversity of Coimbra · PT

Funding

Stable, High Relaxivity MRI Contrast AgentsR01EB009062 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2009 to 2017
$4.9M
Molecular Imaging of Liver FibrosisR01DK104956 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TANABE, KENNETH K · 2015 to 2019
$2.7M
Molecular Imaging of Renal FibrogenesisU01DK104302 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2014 to 2019
$2.1M
HPLC-ICP-MS SystemS10OD010650 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2013 to 2013
$371k
NIBIB NIH HHS R01 EB009062NIDDK NIH HHS R01 DK104956NIDDK NIH HHS U01 DK104302NIH HHS S10 OD010650
6 · The paper itself

Abstract

RATIONALE AND

objectivesLiver inflammation is associated with nonalcoholic steatohepatitis and other pathologies, but noninvasive methods to assess liver inflammation are limited. Inflammation causes endothelial disruption and leakage of plasma proteins into the interstitial space and can result in extravascular coagulation with fibrin deposition. Here we assess the feasibility of using the established fibrin-specific magnetic resonance probe EP-2104R for the noninvasive imaging of fibrin as a marker of liver inflammation.

methodsWeekly 100 mg/kg diethylnitrosamine (DEN) dosing was used to generate liver fibrosis in male rats; control animals received vehicle. Magnetic resonance imaging at 1.5 T with EP-2104R, a matched non-fibrin-binding control linear peptide, or the collagen-specific probe EP-3533 was performed at 1 day or 7 days after the last DEN administration. Imaging data were compared with quantitative histological measures of fibrosis and inflammation.

resultsAfter 4 or 5 DEN administrations, the liver becomes moderately fibrotic, and fibrosis is the same if the animal is killed 1 day (Ishak score, 3.62 ± 0.31) or 7 days (Ishak score, 3.82 ± 0.25) after the last DEN dose, but inflammation is significantly higher at 1 day compared with 7 days after the last DEN dose (histological activity index from 0-4, 3.54 ± 0.14 vs 1.61 ± 0.16, respectively; P < 0.0001). Peak EP-2104R signal enhancement was significantly higher in animals imaged at 1 day post-DEN compared with 7 days post-DEN or control rats (29.0% ± 3.2% vs 22.4% ± 2.0% vs 17.0% ± 0.2%, respectively; P = 0.017). Signal enhancement with EP-2104R was significantly higher than control linear peptide at 1 day post-DEN but not at 7 days post-DEN indicating specific fibrin binding during the inflammatory phase. Collagen molecular magnetic resonance with EP-3533 showed equivalent T1 change when imaging rats 1 day or 7 days post-DEN, consistent with equivalent fibrosis.

conclusionsEP-2104R can specifically detect fibrin associated with inflammation in a rat model of liver inflammation and fibrosis.

Indexed as

AnimalsDisease Models, AnimalFibrinGadoliniumInflammationLiverLiver CirrhosisMagnetic Resonance ImagingMalePeptidesRatsRats, WistarEP-2104RFibrinGadoliniumPeptides

Identifiers

PMID31895219
PMCPMC7935409
OpenAlexW2997052789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.